NurExone Biologic Inc. (TSXV:NRX)
Canada
· Delayed Price · Currency is CAD 0.590
-0.005 (-0.84%)
Feb 21, 2025, 4:00 PM EST
NurExone Biologic Market Cap
NurExone Biologic has a market cap or net worth of CAD 43.60 million as of February 21, 2025. Its market cap has increased by 181.34% in one year.
Market Cap
43.60M
Enterprise Value
40.23M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
0.59
Market Cap Chart
Since June 23, 2022, NurExone Biologic's market cap has increased from 33.48M to 43.60M, an increase of 30.20%. That is a compound annual growth rate of 10.40%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 21, 2025 | 43.60M | -0.82% |
| Dec 31, 2024 | 43.95M | 208.80% |
| Dec 28, 2023 | 14.23M | -14.84% |
| Dec 22, 2022 | 16.71M | -50.08% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Green Thumb Industries | 2.41B |
| Curaleaf Holdings | 1.55B |
| WELL Health Technologies | 1.53B |
| dentalcorp Holdings | 1.53B |
| Sienna Senior Living | 1.27B |
| Trulieve Cannabis | 1.19B |
| Cronos Group | 1.06B |
| Extendicare | 955.70M |